scispace - formally typeset
R

Ryu Kanzaki

Researcher at Osaka University

Publications -  85
Citations -  960

Ryu Kanzaki is an academic researcher from Osaka University. The author has contributed to research in topics: Lung cancer & Metastasectomy. The author has an hindex of 14, co-authored 79 publications receiving 757 citations.

Papers
More filters
Journal ArticleDOI

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

TL;DR: The contemporary literature on the surgical management of metastatic BCa and factors associated with outcomes are reviewed to support the development of clinical guidelines as well as informed clinical decision-making.
Journal ArticleDOI

Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.

TL;DR: Adenocarcinoma, tumors located in the upper or middle lobe, tumor size >3 cm, and SUV(max) of primary tumor >4.0 g/ml are risk factors for occult MLN metastasis in patients with NSCLC who were diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT.
Journal ArticleDOI

Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience

TL;DR: Surgical resection of pulmonary metastasis from RCC has a favourable outcome in selected patients, DFI and completeness of resection are prognostic markers for survival after pulmonary metastasectomy and repeat lung resection for metastatic RCC is a safe procedure that provides satisfactory patient outcomes.
Journal ArticleDOI

Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma

TL;DR: In this paper, the outcomes after repeat pulmonary resection for colorectal cancer (CRC) and the factors associated with the prognosis of these patients remain uncharacterized.
Journal ArticleDOI

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients

TL;DR: In this paper, the clinical value of FDG-PET/CT in a large number of patients with non-small cell lung cancer (NSCLC) after potentially curative surgery was examined.